KRAS and pancreatic neoplasm: Furthermore, inhibition of MEK, but not AKT, by small molecules downregulated the expression of LIF in human pancreatic cancer cell line Panc1.0, suggesting that the MEK/ERK signaling pathway is essential for regulation of LIF expression by KRAS (Fig. 2a).